Curculigoside B

Curculigoside B

SCHEMBL7953777

COc1cccc(O)c1C(=O)OCc1cc(O)ccc1OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC28A3 Q9HAS3 4/20 0.60
SLC5A1 P13866 3/20 0.57
TYR P14679 2/20 0.52
TYMP P19971 1/20 0.51
DYRK1A Q13627 1/20 0.49
ACHE P22303 1/20 0.48
SNCA P37840 1/20 0.48
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
RECQL P46063 1/20 0.47
HIF1A Q16665 1/20 0.47
SLC5A2 P31639 1/20 0.47
KDM1A O60341 1/20 0.47
EPHX2 P34913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Curculigoside B SCHEMBL29419859 1.00 SLC28A3 (0.60) SLC28A3SLC5A1TYRTYMPDYRK1A
Curculigoside A SCHEMBL29419841 0.95 SLC28A3 (0.55) SLC28A3SLC5A1TYRTYMPDYRK1A
SCHEMBL2962105 0.89 SLC28A3 (0.47) SLC28A3SLC5A1TYRTYMPDYRK1A
SCHEMBL2948198 0.84 SLC28A3 (0.42) SLC28A3SLC5A1TYRTYMPDYRK1A
Salireposide SCHEMBL29891482 0.81 TYMP (0.66) SLC28A3SLC5A1TYRTYMPSLC5A2
SCHEMBL943236 0.81 SLC28A3 (0.74) SLC28A3SLC5A1TYRHIF1ASLC5A2
SCHEMBL940443 0.81 SLC28A3 (0.78) SLC28A3SLC5A1TYRSNCAHIF1A
SCHEMBL942070 0.79 SLC28A3 (0.71) SLC28A3SLC5A1TYRKDM4EHIF1A
SCHEMBL940116 0.76 SLC28A3 (0.81) SLC28A3SLC5A1TYRKDM4ERECQL
SCHEMBL30803061 0.76 SLC28A3 (0.57) SLC28A3SLC5A1TYRTYMPHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6264994-B1 Compositions for treating alzheimer's disease and other amyloidoses UNIVERSITY OF WASHINGTON 2001-07-24 US disclosed